Richard Olsen

Richard Olsen is an experienced professional in the healthcare and biotechnology sectors, currently serving as Director of Oncology Channel Collaborations at Natera since May 2021. In this role, Richard leads partnerships with academic institutions, integrated delivery networks (IDNs), and major community networks to enhance KOL development, data integration, and clinical trials for the Oncology Franchise. Prior to Natera, Richard held positions including National Account Manager at Adaptive Biotechnologies, where efforts focused on increasing adoption of the clonoSEQ® assay, and Senior Director of Commercial Operations & Strategic Accounts at Intermountain Healthcare's Navican Genomics. Richard's extensive career also includes leadership roles at Miraca Life Sciences, DiagnoCure Oncology Laboratories, Johnson & Johnson, and Bayer Pharmaceuticals, showcasing a strong background in sales, business development, and strategic account management in the oncology space. Richard holds an MBA in Marketing Management from Pace University and a BS in Finance from Seton Hall University.